|
|
Volumn 79, Issue 7, 2012, Pages 1090-1091
|
|
The effect of differing pharmacologic strategies on infarct size in primary PCI - More confirmatory data for bivalirudin
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABCIXIMAB;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
HIRULOG;
ADJUVANT THERAPY;
BLEEDING;
BLOOD VESSEL OCCLUSION;
CARDIOVASCULAR MAGNETIC RESONANCE;
CLINICAL TRIAL (TOPIC);
CORONARY ARTERY THROMBOSIS;
CORONARY FLOW RESERVE;
DRUG PREFERENCE;
HEART INFARCTION SIZE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME;
HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME;
HEART LEFT VENTRICLE PERFORMANCE;
HEART LEFT VENTRICLE VOLUME;
HEART MUSCLE PERFUSION;
HUMAN;
IMAGE ANALYSIS;
MICROANGIOPATHY;
MORTALITY;
NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
NOTE;
OUTCOME ASSESSMENT;
PERCUTANEOUS CORONARY INTERVENTION;
PRACTICE GUIDELINE;
PROGNOSIS;
RISK REDUCTION;
ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;
STENT THROMBOSIS;
THROMBOCYTE AGGREGATION INHIBITION;
ANGIOPLASTY, BALLOON, CORONARY;
ANTIBODIES, MONOCLONAL;
ANTICOAGULANTS;
ANTITHROMBINS;
FEMALE;
HEPARIN;
HIRUDINS;
HUMANS;
IMMUNOGLOBULIN FAB FRAGMENTS;
MAGNETIC RESONANCE IMAGING, CINE;
MALE;
MYOCARDIAL INFARCTION;
MYOCARDIUM;
PEPTIDE FRAGMENTS;
PLATELET AGGREGATION INHIBITORS;
RECOMBINANT PROTEINS;
|
|
EID: 84861990578
PISSN: 15221946
EISSN: 1522726X
Source Type: Journal
DOI: 10.1002/ccd.24455 Document Type: Note |
|
Times cited : (1)
|
|
References (6)
|
